MedTrace Logo

Self- Administered Acupressure for Diarrhea Predominant Irritable Bowel Syndrome

NCT05702255 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2024-04-30

No results posted yet for this study

Summary

This study aims to assess the effect of active self- administered acupressure compared to sham self- administered acupressure on the health outcome for patient with diarrhea predominant Irritable Bowel Syndrome

Conditions

  • Irritable Bowel Syndrome With Diarrhea

Interventions

OTHER

Active acupressure

Participants will receive training (2 sessions, 2 days a part) by a training researcher. Patients will be taught on the acupoints location and the acupressure technique. Participants will be verified for the correct location of the acupoints, acupressure technique and strength. Participants will be instructed to use thumb or middle finger to self- press each acupoint using circular movements. The force of pressing must be sufficiently strong but still within a comfortable range. A lubricant will be uses to decrease friction between the acupoints and the finger. Follow up evaluation will be at the end of the week 2 and week 4 .The training researcher will make weekly calls to remind participants to perform acupressure and to answer questions

OTHER

Sham acuptressure

The same protocol as the active acupressure group.

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Maha G Asal, Phd · Alexandria University

  • Zahraa H Ramzy, Phd · Alexandria University

  • Rasha F Ahmed, Phd · Alexandria University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-05
Primary Completion
2023-08-28
Completion
2023-08-28

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05702255 on ClinicalTrials.gov